Clinical Trials
7 trialsNCT00949247 2020-07-27
Docetaxel,Carboplatin,Trastuzumab and Bevacizumab for Breast Cancer and Bone Marrow Micrometastases
Case Comprehensive Cancer Center
Phase EARLY_PHASE1 Completed
NCT02802098 2020-06-19
Abrogation of Chronic Monoclonal Antibody Treatment-induced T-cell Exhaustion With DURVALUMAB in Advanced HER-2 Negative Breast Cancer
Centro Nacional de Investigaciones Oncologicas CARLOS III
Phase EARLY_PHASE1 Completed
NCT02806817 2019-07-23
ME-344 in Early HER2-negative Breast Cancer With Antiangiogenic-induced Mitochondrial Metabolism
Centro Nacional de Investigaciones Oncologicas CARLOS III
Phase EARLY_PHASE1 Completed
NCT02768389 2019-03-15
Feasibility Trial of the Modified Atkins Diet and Bevacizumab for Recurrent Glioblastoma
Case Comprehensive Cancer Center
Phase EARLY_PHASE1 Completed
NCT01091792 2018-05-25
Exploratory Study of the Modulation of the Immune System by VEGF Blockade in Patients With Glioblastoma Multiforme (GBM)
Dartmouth-Hitchcock Medical Center
Phase EARLY_PHASE1 Completed
NCT00890786 2018-05-02
A Study of Bevacizumab Therapy in Patients With Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine Gliomas
Children's Hospital Medical Center, Cincinnati
Phase EARLY_PHASE1 Completed
NCT00140556 2013-01-18
Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer
Duke University
Phase EARLY_PHASE1 Completed